DSGNBoard•globenewswire•
Design Therapeutics Appoints Justin Gover to Board of Directors
Sentiment:Negative (20)
Summary
(NASDAQ:DSGN) CARLSBAD, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the appointment of industry veteran Justin Gover to its Board of Directors, effective immediately.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 10, 2025 by globenewswire